Analysis of cribriform Gleason grade 3 in prostatic carcinoma. A histopathological and immunohistochemical study of 32 cases [7]

Histopathology

Volumn 51, Issue 5, 2007, Pages 717-719

  Martinez Rodriguez, M ^a   Ramos, D ^a   Mayordomo, E ^a   Soriano, P ^a   Llombart Bosch, A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA;

ADENOCARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 35348880931     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02834.x     Document Type: Letter

References (6)

1. Epstein JI, Allsbrook WC, Amin MB et al. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 2005 29 1228 1242.
2. Lopez-Beltran A, Mikuz G, Luque RJ et al. Current practice of Gleason grading of prostate carcinoma. Virchows Arch. 2006 448 111 118.
3. Kronz JD, Shaikh AA, Epstein JI. Atypical cribriform lesions on prostate biopsy. Am. J. Surg. Pathol. 2001 25 147 155.
4. Rubin MA, Taille A, Bagiella E et al. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia. Am. J. Surg. Pathol. 1998 22 840 848.
5. Montironi R, Vela R, Lopez-Beltran A et al. Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Arch. 2006 499 1 13.
6. Amin MB, Schultz DS, Zarbo RJ. Analysis of cribriform morphology in prostatic neoplasia using antibody to high-molecular-weight cytokeratins. Arch. Pathol. Lab. Med. 1994 118 260 264.